147 related articles for article (PubMed ID: 25630537)
1. Differential characteristics of CD133(+) and CD133 (-) Jurkat cells.
Anbarlou A; Atashi A; Soleimani M; AkhavanRahnama M; Bohloli M; Mossahebi-Mohammadi M
In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):556-61. PubMed ID: 25630537
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
3. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
4. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
6. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
[TBL] [Abstract][Full Text] [Related]
7. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma].
Lin TT; Zhu LM; He YJ; Zhang H
Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S
Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104
[TBL] [Abstract][Full Text] [Related]
11. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.
Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA
Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377
[TBL] [Abstract][Full Text] [Related]
12. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
13. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract][Full Text] [Related]
15. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH
PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434
[TBL] [Abstract][Full Text] [Related]
16. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
Lin F; Yan W; Wen T; Wu GY
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094
[TBL] [Abstract][Full Text] [Related]
17. CD133 as a marker for cancer stem cells: progresses and concerns.
Wu Y; Wu PY
Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
[TBL] [Abstract][Full Text] [Related]
18. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
20. CD133+ human colorectal adenocarcinoma cells are resistant to staining with fluorescent dyes used for analysis of ABC transporter activities.
Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Frank GA; Yarygin KN
Bull Exp Biol Med; 2014 Nov; 158(1):80-3. PubMed ID: 25403403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]